Filed: 2/14/2024ACC: 0001420506-24-000388
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 67 equity positions with a total reported market value of $335.96M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
67
Positions
$335.96M
Total AUM (reported)
41.02M
Total Shares
Allocation by class
EQUITIES$324.19M96.5%
LONG OPTION CALLS$11.72M3.5%
WARRANTS$51.4K0.0%
Portfolio Concentration
Top 3$47.09M14.0%
4–10$83.06M24.7%
11–25$102.82M30.6%
Rest$103.00M30.7%
Top 3 weight
14.0%
Top 10 weight
38.7%
Voting Authority Distribution
Total shares with voting rights: 41.02M
Sole
Full voting authority
41.02M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole67
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings67
Rows:
Merus NV
SOLEShares645.58K
TypeSH
Market value$17.75M
5.28%
Sole
645.58K
Shared
0.00
None
0.00
Mersana Therapeutics Inc
SOLEShares6.42M
TypeSH
Market value$14.89M
4.43%
Sole
6.42M
Shared
0.00
None
0.00
Morphic Holding Inc
SOLEShares500.04K
TypeSH
Market value$14.44M
4.30%
Sole
500.04K
Shared
0.00
None
0.00
Nuvalent Inc
SOLEShares193K
TypeSH
Market value$14.20M
4.23%
Sole
193K
Shared
0.00
None
0.00
Poseida Therapeutics Inc
SOLEShares3.71M
TypeSH
Market value$12.45M
3.71%
Sole
3.71M
Shared
0.00
None
0.00
MacroGenics Inc
SOLEShares1.26M
TypeSH
Market value$12.11M
3.60%
Sole
1.26M
Shared
0.00
None
0.00
Rocket Pharmaceuticals Inc
SOLEShares382.67K
TypeSH
Market value$11.47M
3.41%
Sole
382.67K
Shared
0.00
None
0.00
Medtronic PLC
SOLEShares135K
TypeSH
Market value$11.12M
3.31%
Sole
135K
Shared
0.00
None
0.00
Sanofi SA
SOLEShares220K
TypeSH
Market value$10.94M
3.26%
Sole
220K
Shared
0.00
None
0.00
Oric Pharmaceuticals Inc
SOLEShares1.17M
TypeSH
Market value$10.76M
3.20%
Sole
1.17M
Shared
0.00
None
0.00
Celldex Therapeutics Inc
SOLEShares247.22K
TypeSH
Market value$9.80M
2.92%
Sole
247.22K
Shared
0.00
None
0.00
Mirati Therapeutics Inc
SOLEShares150K
TypeSH
Market value$8.81M
2.62%
Sole
150K
Shared
0.00
None
0.00
Olema Pharmaceuticals Inc
SOLEShares573.83K
TypeSH
Market value$8.05M
2.40%
Sole
573.83K
Shared
0.00
None
0.00
Rhythm Pharmaceuticals Inc
SOLEShares174.25K
TypeSH
Market value$8.01M
2.38%
Sole
174.25K
Shared
0.00
None
0.00
Urogen Pharma Ltd
SOLEShares525.40K
TypeSH
Market value$7.88M
2.35%
Sole
525.40K
Shared
0.00
None
0.00
Xenon Pharmaceuticals Inc
SOLEShares163.17K
TypeSH
Market value$7.52M
2.24%
Sole
163.17K
Shared
0.00
None
0.00
Veracyte Inc
SOLEShares247.72K
TypeSH
Market value$6.81M
2.03%
Sole
247.72K
Shared
0.00
None
0.00
Praxis Precision Medicines Inc
SOLEShares283.84K
TypeSH
Market value$6.32M
1.88%
Sole
283.84K
Shared
0.00
None
0.00
Akero Therapeutics Inc
SOLEShares249.25K
TypeSH
Market value$5.82M
1.73%
Sole
249.25K
Shared
0.00
None
0.00
Pliant Therapeutics Inc
SOLEShares318.52K
TypeSH
Market value$5.77M
1.72%
Sole
318.52K
Shared
0.00
None
0.00
Intra-Cellular Therapies Inc
SOLEShares80K
TypeSH
Market value$5.73M
1.71%
Sole
80K
Shared
0.00
None
0.00
Cogent Biosciences Inc
SOLEShares966.75K
TypeSH
Market value$5.68M
1.69%
Sole
966.75K
Shared
0.00
None
0.00
Alpine Immune Sciences Inc
SOLEShares297.79K
TypeSH
Market value$5.68M
1.69%
Sole
297.79K
Shared
0.00
None
0.00
Gossamer Bio Inc
SOLEShares6.13M
TypeSH
Market value$5.59M
1.67%
Sole
6.13M
Shared
0.00
None
0.00
Intuitive Surgical Inc
SOLEShares15.81K
TypeSH
Market value$5.33M
1.59%
Sole
15.81K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Merus NVSOLE | EQUITIES | 645.58K | SH | $17.75M 5.28% | 645.58K | 0.00 | 0.00 |
Mersana Therapeutics IncSOLE | EQUITIES | 6.42M | SH | $14.89M 4.43% | 6.42M | 0.00 | 0.00 |
Morphic Holding IncSOLE | EQUITIES | 500.04K | SH | $14.44M 4.30% | 500.04K | 0.00 | 0.00 |
Nuvalent IncSOLE | EQUITIES | 193K | SH | $14.20M 4.23% | 193K | 0.00 | 0.00 |
Poseida Therapeutics IncSOLE | EQUITIES | 3.71M | SH | $12.45M 3.71% | 3.71M | 0.00 | 0.00 |
MacroGenics IncSOLE | EQUITIES | 1.26M | SH | $12.11M 3.60% | 1.26M | 0.00 | 0.00 |
Rocket Pharmaceuticals IncSOLE | EQUITIES | 382.67K | SH | $11.47M 3.41% | 382.67K | 0.00 | 0.00 |
Medtronic PLCSOLE | EQUITIES | 135K | SH | $11.12M 3.31% | 135K | 0.00 | 0.00 |
Sanofi SASOLE | EQUITIES | 220K | SH | $10.94M 3.26% | 220K | 0.00 | 0.00 |
Oric Pharmaceuticals IncSOLE | EQUITIES | 1.17M | SH | $10.76M 3.20% | 1.17M | 0.00 | 0.00 |
Celldex Therapeutics IncSOLE | EQUITIES | 247.22K | SH | $9.80M 2.92% | 247.22K | 0.00 | 0.00 |
Mirati Therapeutics IncSOLE | LONG OPTION CALLS | 150K | SH | $8.81M 2.62% | 150K | 0.00 | 0.00 |
Olema Pharmaceuticals IncSOLE | EQUITIES | 573.83K | SH | $8.05M 2.40% | 573.83K | 0.00 | 0.00 |
Rhythm Pharmaceuticals IncSOLE | EQUITIES | 174.25K | SH | $8.01M 2.38% | 174.25K | 0.00 | 0.00 |
Urogen Pharma LtdSOLE | EQUITIES | 525.40K | SH | $7.88M 2.35% | 525.40K | 0.00 | 0.00 |
Xenon Pharmaceuticals IncSOLE | EQUITIES | 163.17K | SH | $7.52M 2.24% | 163.17K | 0.00 | 0.00 |
Veracyte IncSOLE | EQUITIES | 247.72K | SH | $6.81M 2.03% | 247.72K | 0.00 | 0.00 |
Praxis Precision Medicines IncSOLE | EQUITIES | 283.84K | SH | $6.32M 1.88% | 283.84K | 0.00 | 0.00 |
Akero Therapeutics IncSOLE | EQUITIES | 249.25K | SH | $5.82M 1.73% | 249.25K | 0.00 | 0.00 |
Pliant Therapeutics IncSOLE | EQUITIES | 318.52K | SH | $5.77M 1.72% | 318.52K | 0.00 | 0.00 |
Intra-Cellular Therapies IncSOLE | EQUITIES | 80K | SH | $5.73M 1.71% | 80K | 0.00 | 0.00 |
Cogent Biosciences IncSOLE | EQUITIES | 966.75K | SH | $5.68M 1.69% | 966.75K | 0.00 | 0.00 |
Alpine Immune Sciences IncSOLE | EQUITIES | 297.79K | SH | $5.68M 1.69% | 297.79K | 0.00 | 0.00 |
Gossamer Bio IncSOLE | EQUITIES | 6.13M | SH | $5.59M 1.67% | 6.13M | 0.00 | 0.00 |
Intuitive Surgical IncSOLE | EQUITIES | 15.81K | SH | $5.33M 1.59% | 15.81K | 0.00 | 0.00 |
Page 1 of 3